Evidence map›Paper›PMID 39801712›Full record

ArticleBrain communications2025

Locus coeruleus signal intensity and emotion regulation in agitation in Alzheimer's disease.

Kathy Y Liu, Matthew J Betts, Dorothea Hämmerer, Emrah Düzel, Mara Mather, Jonathan P Roiser, Anja Schneider, Annika Spottke, Ayda Rostamzadeh, Björn H Schott and 28 more

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Kathy Y LiuDivision of Psychiatry, University College London, London W1T 7NF, UK.ORCID https://orcid.org/0000-0002-7482-2758
Matthew J BettsGerman Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.
Dorothea HämmererGerman Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.
Emrah DüzelGerman Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.ORCID https://orcid.org/0000-0002-0139-5388
Mara MatherLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.ORCID https://orcid.org/0000-0003-4331-6112
Jonathan P RoiserInstitute of Cognitive Neuroscience, University College London, London WC1N 3AZ, UK.
Anja SchneiderGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Annika SpottkeGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Ayda RostamzadehDepartment of Psychiatry, University of Cologne, Medical Faculty, 50924 Cologne, Germany.
Björn H SchottCBBS Center for Behavioral Brain Sciences, 39106 Magdeburg, Germany.ORCID https://orcid.org/0000-0002-8237-4481
Boris-Stephan RauchmannDepartment of Psychiatry and Psychotherapy, University Hospital, 80336 Munich, Germany.
Christoph LaskeGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany.
Daniel JanowitzInstitute for Stroke and Dementia Research (ISD), University Hospital, 81377 Munich, Germany.
Eike J SpruthGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Ersin ErsözlüGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Falk LüsebrinkGerman Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.
Frank JessenGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Ingo FrommannGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Ingo KilimannGerman Center for Neurodegenerative Diseases (DZNE), 18147 Rostock, Germany.
Jens WiltfangGerman Center for Neurodegenerative Diseases (DZNE), 37075 Goettingen, Germany.
Johanna BrustkernGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Josef PrillerGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Julian Hellman-RegenGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Katharina BuergerInstitute for Stroke and Dementia Research (ISD), University Hospital, 81377 Munich, Germany.
Klaus FliessbachGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Klaus SchefflerDepartment for Biomedical Magnetic Resonance, University of Tübingen, 72076 Tübingen, Germany.
Luca KleineidamGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Melina StarkGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Michael EwersGerman Center for Neurodegenerative Diseases (DZNE, Munich), 81377 Munich, Germany.ORCID https://orcid.org/0000-0001-5231-1714
Michael WagnerGerman Center for Neurodegenerative Diseases (DZNE), 53127 Bonn, Germany.
Oliver PetersGerman Center for Neurodegenerative Diseases (DZNE), 10117 Berlin, Germany.
Peter DechentMR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University Goettingen, 37075 Goettingen, Germany.
Robert PerneczkyDepartment of Psychiatry and Psychotherapy, University Hospital, 80336 Munich, Germany.
Sebastian SodenkampGerman Center for Neurodegenerative Diseases (DZNE), 72076 Tübingen, Germany.
Stefan HetzerBerlin Center for Advanced Neuroimaging, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
Stefan TeipelGerman Center for Neurodegenerative Diseases (DZNE), 18147 Rostock, Germany.ORCID https://orcid.org/0000-0002-3586-3194
Wenzel GlanzGerman Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany.
Robert HowardDivision of Psychiatry, University College London, London W1T 7NF, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperphosphorylated tau accumulation is seen in the noradrenergic locus coeruleus from the earliest stages of Alzheimer's disease onwards and has been associated with symptoms of agitation. It is hypothesized that compensatory locus coeruleus-noradrenaline system overactivity and impaired emotion regulation could underlie agitation propensity, but to our knowledge this has not previously been investigated. A better understanding of the neurobiological underpinnings of agitation would help the development of targeted prevention and treatment strategies. Using a sample of individuals with amnestic mild cognitive impairment and probable mild Alzheimer's disease dementia from the German Center for Neurodegenerative Diseases (DZNE)-Longitudinal Cognitive Impairment and Dementia (DELCODE) study cohort (

Indexed as

agitationAlzheimerautonomicemotion regulationlocus coeruleus

Identifiers

PMID39801712
PMCPMC11724426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.